How do mRNA COVID-19 vaccines work?
2:28
YouTubePBS NewsHour
How do mRNA COVID-19 vaccines work?
The first COVID-19 vaccines represent an incredible record-breaking achievement in vaccine development. Not only were the Moderna and Pfizer/BioNTech vaccines created in record time, they also harness a never-before-used technology: immunization through mRNA. But how do these vaccines protect us and how do they differ from other vaccines? These ...
416.1K viewsMar 10, 2021
COVID-19 vaccine COVAX Initiative
First COVID-19 vaccine doses from COVAX arrive in Africa
2:53
First COVID-19 vaccine doses from COVAX arrive in Africa
Global NewsFrancis Kokutse,Carley
Feb 24, 2021
What is COVAX?
1:10
What is COVAX?
ABC NewsMorgan Winsor
Feb 26, 2021
5 Things to Know About COVAX , the Life-Saving Vaccine Initiative
5 Things to Know About COVAX , the Life-Saving Vaccine Initiative
globalcitizen.org
Mar 9, 2021
Top videos
How vaccines work against COVID-19: Science, Simplified
2:16
How vaccines work against COVID-19: Science, Simplified
YouTubeScripps Research
1.1M viewsDec 18, 2020
What The COVID Vaccine Does To Your Body
5:34
What The COVID Vaccine Does To Your Body
YouTubeAsapSCIENCE
12.9M viewsDec 8, 2020
There are four types of COVID-19 vaccines: here’s how they work
4:10
There are four types of COVID-19 vaccines: here’s how they work
YouTubeGavi, the Vaccine Alliance
1.9M viewsDec 18, 2020
COVID-19 vaccine Breakthrough Infections
1. How mRNA Vaccines and Vaccine Breakthrough Infections Drive Viral Immune Escape Dynamics
1. How mRNA Vaccines and Vaccine Breakthrough Infections Drive Viral Immune Escape Dynamics
rumble.com
1 month ago
What causes breakthrough measles infections even if someone is vaccinated?
1:12
What causes breakthrough measles infections even if someone is vaccinated?
NBC NewsDavid Cox
8 months ago
13K views · 186 reactions | Indian pharma company Zydus has said it has started human studies for its potential Covid-19 vaccine. ZyCoV-D, its plasmid DNA vaccine, was found to be safe, immunogenic and well-tolerated in the pre-clinical toxicity studies. Zydus will enrol over 1,000 subjects across multiple clinical study sites in India in the human trials. Vaccines are awaited as coronavirus infections continue to surge in the world's third worst-hit nation. | The Times of India | Facebook
0:37
13K views · 186 reactions | Indian pharma company Zydus has said it has started human studies for its potential Covid-19 vaccine. ZyCoV-D, its plasmid DNA vaccine, was found to be safe, immunogenic and well-tolerated in the pre-clinical toxicity studies. Zydus will enrol over 1,000 subjects across multiple clinical study sites in India in the human trials. Vaccines are awaited as coronavirus infections continue to surge in the world's third worst-hit nation. | The Times of India | Facebook
FacebookThe Times of India
13.9K views2 weeks ago